Drug Inducible CRISPR/Cas Systems
Clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) systems have been employed as a powerful versatile technology for programmable gene editing, transcriptional modulation, epigenetic modulation, and genome labeling, etc. Yet better control of their a...
Main Authors: | Jingfang Zhang, Li Chen, Ju Zhang, Yu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037018303568 |
Similar Items
-
HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
by: Chen Zhao, et al.
Published: (2018-12-01) -
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
by: Yinnan Chen, et al.
Published: (2018-06-01) -
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01) -
Association of CRISPR/Cas System with the Drug Resistance in Klebsiella pneumoniae
by: Wang G, et al.
Published: (2020-06-01) -
Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening
by: Ning Sun, et al.
Published: (2019-03-01)